Semaglutide

A GLP-1 receptor agonist extensively studied for appetite suppression, weight loss, and glucose control.

In the literature, Semaglutide appears most often in work focused on weight loss, appetite control and blood sugar. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.

Semaglutide is catalogued here under powder peptides. Coverage of this compound varies in quality and depth, and much of it remains early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.